secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2023-09-25T23:59:59+00:00
Accession:  0001453687-23-000064
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Selecta Biosciences approves retention bonuses for five executives
------------------------------------------------------------------

- Carsten Brunn (CEO) and Blaine Davis each receive 2x annual salary bonus; Peter Traber 1.5x; Takashi Kei Kishimoto 1x; Lloyd Johnston 2x.
- Bonus payable on first payroll after March 31, 2024 if executive remains employed in good standing.
- Compensation Committee may accelerate payment or waive service requirements at its discretion.
- Retention bonuses aim to incentivize key leadership continuity through March 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368723000064/0001453687-23-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368723000064/selb-20230825.htm
  HTML page:      https://secwatch.observer/filing/0001453687-23-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer